AtriCure Inc
ATRC37.110USD
+0.910+2.51%
Handelsschluss 02/06, 16:00（ET）Kurse um 15 Minuten verzögert
1.84BMarktkapitalisierung
VerlustKGV TTM
mehr Informationen über AtriCure Inc Unternehmen
AtriCure, Inc. provides technologies for the treatment for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management. The Company's cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Its pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures. The Company's products for open and minimally invasive ablation include Isolator Synergy Clamps and Multifunctional Pens and Linear Ablation Devices. Its products for open ablation include cryoICE Cryoablation System. Its products for minimally invasive ablation include EPi-Sense Guided Coagulation System with VisiTrax Technology. Its appendage management products include AtriClip System. The Isolator Synergy Ablation System clamps are single-use disposable radio frequency (RF) products with jaws that close in a parallel fashion.
AtriCure Inc Informationen
BörsenkürzelATRC
Name des UnternehmensAtriCure Inc
IPO-datumAug 05, 2005
CEOCarrel (Michael H)
Anzahl der mitarbeiter1300
WertpapierartOrdinary Share
GeschäftsjahresendeAug 05
Addresse7555 Innovation Way
StadtMASON
BörseNASDAQ OMX - NASDAQ BASIC
LandUnited States of America
Postleitzahl45040
Telefon15137554100
Websitehttps://www.atricure.com
BörsenkürzelATRC
IPO-datumAug 05, 2005
CEOCarrel (Michael H)
Führungskräfte von AtriCure Inc
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
698.94K
-4000.00%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+822.00%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+15401.00%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-5166.00%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-2500.00%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+822.00%
Mr. Sven A. Wehrwein, CPA
Mr. Sven A. Wehrwein, CPA
Independent Director
Independent Director
34.37K
--
Ms. Regina E. (Reggie) Groves
Ms. Regina E. (Reggie) Groves
Independent Director
Independent Director
33.72K
-2452.00%
Ms. Deborah H. (Deb) Telman
Ms. Deborah H. (Deb) Telman
Independent Director
Independent Director
22.18K
+5401.00%
Mr. Shlomo Nachman
Mr. Shlomo Nachman
Independent Director
Independent Director
18.51K
+5401.00%
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Michael H. (Mike) Carrel, CPA
Mr. Michael H. (Mike) Carrel, CPA
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
698.94K
-4000.00%
Mr. Salvatore Privitera, J.D.
Mr. Salvatore Privitera, J.D.
Chief Technical Officer
Chief Technical Officer
125.59K
+822.00%
Mr. Robert S. (Bob) White
Mr. Robert S. (Bob) White
Independent Chairman of the Board
Independent Chairman of the Board
92.17K
+15401.00%
Mr. Justin J. Noznesky
Mr. Justin J. Noznesky
Chief Marketing and Strategy Officer
Chief Marketing and Strategy Officer
78.80K
-5166.00%
Dr. Vinayak Doraiswamy, Ph.D.
Dr. Vinayak Doraiswamy, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
71.87K
-2500.00%
Mr. Karl S. Dahlquist, J.D.
Mr. Karl S. Dahlquist, J.D.
Chief Legal Officer
Chief Legal Officer
68.55K
+822.00%
Umsatzaufteilung
Währung: USDAktualisiert: Tue, Jan 6
Währung: USDAktualisiert: Tue, Jan 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
Andere
-97.94M
-128.04%
Nach RegionUSD
Name
Umsatz
Anteil
United States
109.31M
81.41%
Europe
15.17M
60.77%
Asia
8.08M
32.38%
Other international
1.71M
6.85%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichUSD
Name
Umsatz
Anteil
Appendage Management-United states
45.45M
33.85%
Open Ablation - United states
35.59M
26.51%
Pain management
20.84M
83.47%
Open ablation -International
10.85M
43.47%
Appendage management -International
10.17M
40.73%
Andere
-97.94M
-128.04%
Aktionärsstatistik
Aktualisiert: Sat, Nov 15
Aktualisiert: Sat, Nov 15
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.84%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
Andere
61.38%
Aktionäre
Aktionäre
Anteil
The Vanguard Group, Inc.
9.84%
Wellington Management Company, LLP
8.63%
AllianceBernstein L.P.
7.16%
BlackRock Institutional Trust Company, N.A.
6.86%
Hood River Capital Management LLC
6.13%
Andere
61.38%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor
51.78%
Investment Advisor/Hedge Fund
39.96%
Hedge Fund
5.87%
Individual Investor
3.47%
Research Firm
1.65%
Pension Fund
0.75%
Bank and Trust
0.52%
Family Office
0.07%
Insurance Company
0.03%
Institutionelle Beteiligung
Aktualisiert: Mon, Dec 8
Aktualisiert: Mon, Dec 8
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q4
492
49.59M
116.79%
-102.71K
2025Q3
520
49.71M
119.25%
-705.98K
2025Q2
524
50.25M
121.23%
-1.55M
2025Q1
527
51.69M
113.33%
-4.41M
2024Q4
514
47.94M
122.38%
-3.05M
2024Q3
505
52.36M
125.18%
-207.95K
2024Q2
494
52.59M
116.92%
+1.07M
2024Q1
500
51.55M
109.93%
-1.63M
2023Q4
498
48.92M
106.78%
+1.54M
2023Q3
486
47.46M
108.31%
+99.25K
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
The Vanguard Group, Inc.
4.83M
9.71%
-65.32K
-1.33%
Sep 30, 2025
Wellington Management Company, LLP
4.29M
8.63%
+322.82K
+8.13%
Sep 30, 2025
AllianceBernstein L.P.
3.56M
7.16%
-15.06K
-0.42%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
3.41M
6.86%
-34.35K
-1.00%
Sep 30, 2025
Hood River Capital Management LLC
3.05M
6.13%
-15.47K
-0.51%
Sep 30, 2025
Nomura Investment Management Business Trust
2.29M
4.6%
-213.84K
-8.54%
Sep 30, 2025
Champlain Investment Partners, LLC
1.98M
3.98%
-38.54K
-1.91%
Sep 30, 2025
State Street Investment Management (US)
1.26M
2.54%
-9.44K
-0.74%
Sep 30, 2025
Neuberger Berman, LLC
1.19M
2.4%
+1.37K
+0.12%
Sep 30, 2025
Geode Capital Management, L.L.C.
1.19M
2.4%
+9.32K
+0.79%
Sep 30, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Dec 6
Aktualisiert: Sat, Dec 6
Name
Anteil
State Street SPDR S&P Health Care Equipment ETF
1.75%
Harbor Human Capital Factor US Small Cap ETF
0.7%
Invesco NASDAQ Future Gen 200 ETF
0.5%
First Trust Small Cap Growth AlphaDEX Fund
0.44%
Fidelity Enhanced Small Cap ETF
0.33%
Amplify Etho Climate Leadership U.S. ETF
0.3%
Franklin US Small Cap Multifactor Index ETF
0.25%
JPMorgan Fundamental Data Science Small Core ETF
0.24%
iShares U.S. Medical Devices ETF
0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.17%
Mehr Anzeigen
State Street SPDR S&P Health Care Equipment ETF
Anteil1.75%
Harbor Human Capital Factor US Small Cap ETF
Anteil0.7%
Invesco NASDAQ Future Gen 200 ETF
Anteil0.5%
First Trust Small Cap Growth AlphaDEX Fund
Anteil0.44%
Fidelity Enhanced Small Cap ETF
Anteil0.33%
Amplify Etho Climate Leadership U.S. ETF
Anteil0.3%
Franklin US Small Cap Multifactor Index ETF
Anteil0.25%
JPMorgan Fundamental Data Science Small Core ETF
Anteil0.24%
iShares U.S. Medical Devices ETF
Anteil0.2%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Anteil0.17%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
0.00
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
Keine Daten
Aktien-Split
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
Datum
Ex-Dividendentag
Art
Verhältnis
Keine Daten
